Project Grant R01HL180298
Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $25K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
- This federal Project Grant award of $220,576.00 was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The award aims to deliver a tobacco treatment implementation (TTI) training program to at least 200 multidisciplinary clinicians from four high-impact care settings: financially impoverished persons, persons with behavioral health and substance use disorders, rural populations, and people living with HIV. The training will focus on...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- The National Heart Lung and Blood Institute awarded Temple University a Project Grant titled "INTEGRATE RX: INTEGRATING CLINICAL PHARMACISTS IN HIV CARE TO MITIGATE LAST-MILE CHALLENGES AND REDUCE CARDIOVASCULAR DISEASE BURDEN" under CFDA Program 93.837 Cardiovascular Diseases Research. The $589,297 grant, awarded on Aug 25, 2025, will evaluate the clinical effectiveness and cost-effectiveness of a multi-component pharmacist-led implementation strategy to prevent and manage...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- This four-year, $4.6 million project grant from the National Institute on Drug Abuse will fund research at the University of Miami exploring the linkage between cannabis use, route of administration, cannabinoid content, and measures of cardiovascular disease (CVD) risk in people living with HIV (PWH). Specifically, the principal investigator - an interventional cardiologist and physician scientist focused on HIV and CVD prevention - will collect comprehensive data on 300 PWH ages 18-60 to...
- This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on developing a cue-based smoking cessation intervention delivered via telehealth for people who smoke lightly (PSLI). The $906,306 award, with a performance period from September 2025 to August 2028, aims to adapt and pilot test an intervention that combines cue-based treatment with standard cognitive behavioral therapy (CBT) to promote smoking cessation...
- This Project Grant award of $962,973.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate a comprehensive curriculum on HIV prevention and implementation science for pharmacy schools in the southern United States. The project, titled "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic through Collaboration with Pharmacy Schools," will be...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and...
- This $2,287,436 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports a study titled "Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-PHARM)." The key objectives are to: 1) assess changes in the availability of HIV and overdose prevention services at community and retail pharmacies in Illinois and North Carolina; 2) examine...